Rising incidences of symptoms such as cancer and cardiac ailments is expected to foster the demand for ablation procedures. Technological advancements to design high-end products and growing demand for treatment procedures, which are minimally invasive are expected to boost the ablation technologies market. Furthermore, rising count of aging population having higher risk of target diseases is another vital factor driving the demand for ablation procedures. However, measures taken by government to control healthcare cost are along with current healthcare reforms in the U.S. may hamper the growth of the market. Moreover, product recalls by companies will hinder the growth of the market. Rising demand of emerging markets along with increasing funding for design of novel ablation devices create abundant growth opportunities to the market. Stringent regulatory framework leading to an increase in the gestation period for product launches is a key market challenge.

The market is segmented on the basis of product, type, application and region. On the basis of type, the market is segmented into light/laser, radiofrequency, electrical, ultrasound, hydromechanical, cryoablation, microwave and hydrothermal. On the basis of products, the market is segmented into laser/light ablators, radiofrequency ablators, ultrasound ablators, radiofrequency ablators, ultrasound ablators, electrical ablators, cryoablation devices, microwave ablators and hydrothermal ablators. The Laser/Light ablators is further segmented into excimer laser ablators and cold laser ablators, where the former is further segmented into ultraviolet B laser ablators. The radiofrequency ablators is further segmented into temperature-controlled radiofrequency ablators, fluid-cooled radiofrequency ablators, robotic catheter manipulation systems. the ultrasound ablators is further segmented into high-intensity focused ultrasound ablators, magnetic resonance-guided focused ultrasound ablators, ultrasonic surgical ablation systems, extracorporeal shockwave lithotripsy systems while electrical ablators is further segmented into argon plasma/beam coagulators and irreversible electroporation ablators. The cryoablation devices is further segmented into tissue contact probes and epidermal and subcutaneous cryoablation devices.

On the basis of application, the market is segmented into general surgery, cardiovascular surgery, cancer, ophthalmology, gynecology, urology, orthopedics, cosmetic surgery and others where the cancer market is further segmented into liver cancer, kidney cancer, prostate cancer, lung cancer, and bone metastasis.

On the basis of geography, North America, Europe, Asia-Pacific, and Latin America, Middle East & Africa (LAMEA).

The report offers information on the status of new projects along with offering investment feasibility analysis of the same.

KEY MARKET SEGMENTS:

Market By Type

Laser/Light Ablation

Radiofrequency Ablation

Ultrasound Ablation

Electrical Ablation

Hydromechanical Ablation

Cryotherapy Ablation

Microwave Ablation

Hydrothermal Ablation

Market By Product

Laser/Light Ablators

Excimer Laser Ablators

Ultraviolet B Laser Ablators

Cold Laser Ablators

Radiofrequency Ablators

Temperature-Controlled Radiofrequency Ablators

Fluid-Cooled Radiofrequency Ablators

Robotic Catheter Manipulation Systems

Ultrasound Ablators

High-Intensity Focused Ultrasound (HIFU) Ablators

Magnetic Resonance-Guided Focused Ultrasound (MRGFUS) Ablators

Ultrasonic Surgical Ablation Systems

Extracorporeal Shockwave Lithotripsy (ESWL) Systems

Electrical Ablators

Argon Plasma/Beam Coagulators

Irreversible Electroporation Ablators

Cryoablation Devices

Tissue Contact Probes

Tissue Spray Probes

Epidermal and Subcutaneous Cryoablation Devices

Microwave Ablators

Hydrothermal Ablators

Market By Application

General Surgery

Cardiovascular Disease Treatment

Cancer Treatment

Liver Cancer

Kidney Cancer

Prostate Cancer

Lung Cancer

Bone Metastasis

Ophthalmological Treatment

Gynecologcal Treatment

Urological Treatment

Orthopedics

Cosmetic Surgery

Others

Market By Region

North America

Europe

Asia-Pacific

LAMEA

Key Company Profile

Covidien PLC

Medtronic, Inc.

Biosense Webster, Inc.

St. Jude Medical, Inc.

Boston Scientific Corporation

Angiodynamics, Inc.

Atricure, Inc.

Conmed Corporation

Olympus Corporation

Smith & Nephew PLC

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR)
encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only
engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates
and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within
each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors
and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis
and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and
allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning

Technologically sophisticated and reliable insights through well audited and veracious research methodology

Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to:
Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.